Intervene Immune
PrivateLast Round
Seed
Dec 27, 2019
Total Funding Raised
$471,000
Company Overview
Intervene Immune operates in Healthcare & Life Sciences and is based in Torrance, California. Its latest recorded funding round was a Seed round in December 2019.
Intervene Immune is a biotechnology company that develops immuno-therapies and diagnostics designed for thymus regeneration and age-related immune system decline.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intervene Immune Comparables
Compare Intervene Immune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TECregen | 77% | |
| United Therapeutics | 77% | |
| Tolerance Bio, Inc. | 68% |
For institutional investors. Book with your work email.
Intervene Immune Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Intervene Immune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevitytech.fund | Seed |
| quadraScope Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 27, 2019
$471K raised from Longevitytech.fund and quadraScope Ventures.
For institutional investors. Book with your work email.
Intervene Immune Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Intervene Immune's valuation, stock price, and market status.
Is Intervene Immune a public or private company?
Intervene Immune is a private company.
What is the current stock price of Intervene Immune?
Intervene Immune is a private company, so its shares have no public market price. Caplight tracks Intervene Immune's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Intervene Immune worth (valuation)?
Valuation information for Intervene Immune is not publicly available.
Can I buy Intervene Immune stock?
Intervene Immune shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Intervene Immune's last funding round?
Intervene Immune's most recent funding round was Seed on December 27, 2019.
Who are the main investors in Intervene Immune?
Key investors in Intervene Immune include Longevitytech.fund, quadraScope Ventures.
Will Intervene Immune IPO soon?
No public IPO plans have been announced for Intervene Immune.
How can I track Intervene Immune secondary market activity?
Caplight tracks bids, offers, and trades in Intervene Immune's shares on secondary markets.